INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2010

Lactobacillus gasseri A5 supplementation improved pulmonary function, symptom scores, and inflammatory cytokines in children with asthma and allergic rhinitis.

School children aged 6-12 years with asthma and allergic rhinitis were randomized to receive Lactobacillus gasseri A5 (n = 49) or placebo (n = 56) daily for 2 months. Compared with controls, probiotic-treated patients showed significant increases in pulmonary function and peak expiratory flow rates, alongside decreased clinical symptom scores for asthma and allergic rhinitis. In addition, probiotic treatment resulted in significant reductions in TNF-α, IFN-γ, IL-12, and IL-13 production by peripheral blood mononuclear cells.

Study type
Randomized, double-blind, placebo-controlled study
Who was studied
105 school children (age 6-12 years) with asthma and allergic rhinitis (49 probiotic, 56 placebo)
What was measured
Pulmonary function, PEFR, asthma and allergic rhinitis symptoms, and PBMC cytokine production

THE PAPER

Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis.

Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. Pediatr Pulmonol, 2010.

PubMed 20658483 ↗DOI 10.1002/ppul.21296 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.